Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Guidance
  • News

Opera Raises FY23 Revenue Outlook $373M – $390M ($370M – $390M Prior) Vs. $382.28M

By Benzinga Newsdesk
April 27, 7:18 AM
Business Outlook “I am very pleased with the opening trajectory of 2023 and while it is only two months since we last spoke, we are cautiously raising the lower-end of our revenue guidance and both ends of our

OPRA

Read More
1 minute read
  • Guidance
  • News

Mobileye Lowers FY23 Revenue Outlook to $2.065B – $2.114B Vs. $2.25B Estimate

By Benzinga Newsdesk
April 27, 6:35 AM
    Full Year 2023   U.S. dollars in

MBLY

Read More
1 minute read
  • Guidance
  • News

Xcel Energy Expects FY23 EPS Of $3.30-$3.40 Vs $3.38 Estimate

By Benzinga Newsdesk
April 27, 6:21 AM
Xcel Energy 2023 Earnings Guidance — Xcel Energy's 2023 GAAP and ongoing earnings guidance is a range of $3.30 to $3.40 per share.(a) Key assumptions as compared

XEL

Read More
1 minute read
  • Guidance
  • News

Honeywell Raises FY23 Outlook: Revenue $36.5B – $37.3B ($36B – $37B Prior) Vs. $36.72B Estimate, EPS $9.00 – $9.25 ($8.80 – $9.20 Prior) Vs. $9.05 Estimate

By Benzinga Newsdesk
April 27, 6:08 AM
    Previous Guidance   Current Guidance Sales   $36.0B - $37.0B   $36.5B -

HON

Read More
2 minute read
  • Biotech
  • Earnings
  • Guidance
  • Health Care
  • Large Cap
  • News

AstraZeneca’s COVID-19 Vaccine Loses Shine, Cancer Drug Imfinzi & Emerging Markets Stabilize Q1 Revenues

By Vandana Singh
April 27, 5:57 AM
AstraZeneca Plc (NASDAQ: AZN) has reported Q1 FY23 core EPS of $1.92, up 1% Y/Y (+6% on constant currency), better than the consensus of $1.07. The company clocked Q1 sales of $10.88 billion, -4% (flat CC), beating the consensus of $10.75 billion.

AZN

Read More
1 minute read
  • Earnings
  • Equities
  • Guidance
  • Markets
  • News
  • Tech

STMicroelectronics Clocks 20% Topline Growth In Q1; Pricing Measures Drive Margins

By Anusuya Lahiri
April 27, 5:50 AM
STMicroelectronics NV (NYSE:  STM) reported first-quarter FY23 revenue growth of 19.8% year-on-year to $4.25 billion, beating the consensus of $4.13 billion.…

STM

Read More
1 minute read
  • Guidance
  • News

Aspen Technology Sees FY23 EPS $5.63-$5.83 Vs $7.06 Est.; Revenue $1.04B-$1.06B Vs $1.17B Est.; Does Not Include Any Contribution From The Acquisition Of Micromine, Which Is Pending Final Regulatory Approval

By Happy Mohamed
April 26, 4:39 PM
Business Outlook Based on information as of today, April 26, 2023, AspenTech is issuing the following guidance for fiscal year 2023. Please note this guidance does not include any contribution

AZPN

Read More
1 minute read
  • Guidance
  • News

Merit Medical Systems Sees FY23 EPS $2.83-$2.93 Vs $2.80-$2.89 Prior Est.; FY23 Revenue $1.217B-$1.229B Vs $1.194B-$1.210B Prior Est.

By Happy Mohamed
April 26, 4:32 PM
Revenue and Earnings Guidance*      Updated Guidance As Reported Prior Guidance % Change Financial Measure December 31, 2023 December 31,

MMSI

Read More
1 minute read
  • Guidance
  • News

KLA Sees Q4 EPS $4.23-$5.43 Vs $4.43 Est.; Revenue $2.125B-$2.375B Vs $2.17B Est.

By Happy Mohamed
April 26, 4:24 PM
Fourth Quarter Fiscal 2023 Guidance The following details our guidance for the fourth quarter of fiscal 2023 ending in June: Total revenues is expected to be

KLAC

Read More
1 minute read
  • Guidance
  • News

CONMED Sees FY23 EPS $3.30-$3.50 Vs $3.20-$3.45 Previous Estimate; FY23 Revenue $1.205B-$1.250B Vs $1.17B-$1.22B Est.

By Happy Mohamed
April 26, 4:21 PM
2023 Outlook Based on the first quarter results, the Company is raising its revenue guidance for the full year 2023 and now expects revenue between $1.205 billion and $1.250 2023 Outlook

CNMD

Posts pagination

Previous 1 … 443 444 445 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service